Source: International Congress 2017 – MDRTB: detection and management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Malic (Chisinau, Republic of Moldova). MDR-TB treatment efficacy according of conventional method and Xpert MTB/RIF results in Republic of Moldova.. 3491

Member's Comments

No comment yet.

Related content which might interest you: MDR-TB treatment efficacy by results of Xpert MTB/RIF assayin the Stavropol region of the Russian Federation Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil Source: ERJ Open Res, 5 (3) 00043-2019; 10.1183/23120541.00043-2019 Year: 2019 How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries? Source: Eur Respir J 2015; 45: 549-554 Year: 2015 Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals Source: Eur Respir J 2016; 47: 575-587 Year: 2016 Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012 Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting Source: Eur Respir J, 51 (3) 1702345; 10.1183/13993003.02345-2017 Year: 2018 Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe Source: Eur Respir J, 51 (5) 1800346; 10.1183/13993003.00346-2018 Year: 2018 Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Early tuberculosis treatment monitoring by Xpert® MTB/RIF Source: Eur Respir J 2012; 39: 1269-1271 Year: 2012 Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis Source: Eur Respir J 2013; 42: 708-720 Year: 2013 Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Clinical utility of the Xpert MTB/RIF test in induced sputum Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India Source: Eur Respir J 2014; 44: 1090-1093 Year: 2014 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis Source: Eur Respir J 2012; 40: 442-447 Year: 2012